U.S. Markets closed

How GlaxoSmithKline Stock Has Performed in September

Mike Benson
How GlaxoSmithKline Stock Has Performed in September

GlaxoSmithKline (GSK), a global pharmaceutical company, is focused on creating a sustainable growth model through expanding its business beyond pharmaceuticals. GlaxoSmithKline reports its financial statements in sterling pounds. GlaxoSmithKline ADR fell marginally by ~0.1% as compared to its previous close to the closing price of $40.51 on September 27.